Related references
Note: Only part of the references are listed.Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2015)
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2015)
Antibodies to watch in 2015
Janice M. Reichert
MABS (2015)
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials
Markus Mandler et al.
ACTA NEUROPATHOLOGICA (2014)
A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells
Aurelien Lathuiliere et al.
BIOMATERIALS (2014)
Genetic engineering of cell lines using lentiviral vectors to achieve antibody secretion following encapsulated implantation
Aurelien Lathuiliere et al.
BIOMATERIALS (2014)
Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders
Veronica Lindstrom et al.
IMMUNOTHERAPY (2014)
Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24 week, double-blind, randomized Phase 3 trial
Eli M. Roth et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Vaccine for Atherosclerosis
Prediman K. Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Jianjun Zhang et al.
SCIENCE (2014)
Allogeneic tumor cell vaccines The promise and limitations in clinical trials
Sanjay Srivatsan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
OPINION Preclinical Alzheimer disease-the challenges ahead
Reisa A. Sperling et al.
NATURE REVIEWS NEUROLOGY (2013)
Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future
Niels D. Prins et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Novel therapeutic vaccines [(HSP65+IL-12) DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy
Yoko Kita et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Therapeutic vaccination against chronic hepatitis C virus infection
Peng Peng Ip et al.
ANTIVIRAL RESEARCH (2012)
Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
Kaj Blennow et al.
ARCHIVES OF NEUROLOGY (2012)
Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery Clinical article
Lars U. Wahlberg et al.
JOURNAL OF NEUROSURGERY (2012)
What's fueling the biotech engine-2011 to 2012
Saurabh (Rob) Aggarwal
NATURE BIOTECHNOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intratumor Heterogeneity: Seeing the Wood for the Trees
Timothy A. Yap et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implants in Patients with Chronic Retinal Degenerative Diseases
Konrad Kauper et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy
F. Schwenter et al.
CANCER GENE THERAPY (2011)
Translating Tumor Antigens into Cancer Vaccines
Luigi Buonaguro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Therapeutic applications of antibodies in non-infectious neurodegenerative diseases
Pavan K. Krishnamurthy et al.
NEW BIOTECHNOLOGY (2011)
Chronic Delivery of Antibody Fragments Using Immunoisolated Cell Implants as a Passive Vaccination Tool
Osiris Marroquin Belaunzaran et al.
PLOS ONE (2011)
Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration
Kang Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antibody Therapy in Neurodegenerative Disease
Amber L Southwell et al.
REVIEWS IN THE NEUROSCIENCES (2011)
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
Geert De Meyer et al.
ARCHIVES OF NEUROLOGY (2010)
Influence of pH on Heat-Induced Aggregation and Degradation of Therapeutic Monoclonal Antibodies
Tomoyoshi Ishikawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid beta After a Single Administration of an Amyloid beta Monoclonal Antibody in Subjects With Alzheimer Disease
Eric R. Siemers et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Allal Boutajangout et al.
JOURNAL OF NEUROSCIENCE (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Therapeutic HIV vaccines show promise
Alison Abbott
NATURE (2010)
Biopharmaceutical benchmarks 2010
Gary Walsh
NATURE BIOTECHNOLOGY (2010)
Change in risk of Alzheimer disease over time
L. E. Hebert et al.
NEUROLOGY (2010)
Vaccine Approaches to Prevent and Treat Prion Infection
Andreas Müller-Schiffmann et al.
BIODRUGS (2009)
Potential aggregation prone regions in biotherapeutics A survey of commercial monoclonal antibodies
Xiaoling Wang et al.
MABS (2009)
Industrialization of mAb production technology The bioprocessing industry at a crossroads
Brian Kelley
MABS (2009)
MARKET WATCH Sales of biologics to show robust growth through to 2013
Michael Goodman
NATURE REVIEWS DRUG DISCOVERY (2009)
The cost effectiveness and budget impact of natalizumab for formulary inclusion
Justin Bakhshai et al.
JOURNAL OF MEDICAL ECONOMICS (2009)
Treatment of diabetic rats with encapsulated islets
Ian R. Sweet et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
The incidence and significance of anti-natalizumab antibodies -: Results from AFFIRM and SENTINEL
P. A. Calabresi et al.
NEUROLOGY (2007)
Proteome analysis of anti body-producing CHO cell lines with different metabolic profiles
Deborah E. Pascoe et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody
Chris Churnsae et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts
Antonella Consiglio et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
G. Parmiani et al.
ANNALS OF ONCOLOGY (2007)
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
The impact of glycosylation on the biological function and structure of human immunoglobulins
James N. Arnold et al.
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Denosumab in postmenopausal women with low bone mineral density
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Inducing tolerance to a soluble foreign antigen by encapsulated cell transplants
WE Blanco-Bose et al.
MOLECULAR THERAPY (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX (R) vaccine in advanced-stage non-small-cell lung cancer
J Nemunaitis et al.
CANCER GENE THERAPY (2006)
Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients
RM Luiten et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Comparative studies of Avipox-GM-CSF versus recombinant GM-CSF protein as immune adjuvants with different vaccine platforms
E Reali et al.
VACCINE (2005)
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
AJ Bayer et al.
NEUROLOGY (2005)
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells
P Serafini et al.
CANCER RESEARCH (2004)
Strategies for disease modification in Alzheimer's disease
M Citron
NATURE REVIEWS NEUROSCIENCE (2004)
Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
S Oddo et al.
NEURON (2004)
Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition
DM Wilcock et al.
JOURNAL OF NEUROSCIENCE (2004)
Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic conditions
F Schwenter et al.
HUMAN GENE THERAPY (2004)
Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection
M das Graças Sasaki et al.
VACCINE (2003)
Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery
BL Schneider et al.
MOLECULAR THERAPY (2003)
Comparative study of GDNF delivery systems for the CNS:: polymer rods, encapsulated cells, and lentiviral vectors
JC Bensadoun et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
S Krapp et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Hollow fiber membrane diffusive permeability regulates encapsulated cell line biomass, proliferation, and small molecule release
KW Broadhead et al.
BIOMATERIALS (2002)
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes:: Clinical and immunologic findings
F Belli et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia
C Rinsch et al.
KIDNEY INTERNATIONAL (2002)
Marked intratumoral heterogeneity of c-myc and CyclinD1 but not of c-erbB2 amplification in breast cancer
S Glöckner et al.
LABORATORY INVESTIGATION (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Immunology of vaccination
PCL Beverley
BRITISH MEDICAL BULLETIN (2002)
Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia
C Rinsch et al.
GENE THERAPY (2001)
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immune activation
EM Jaffee et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Technology of mammalian cell encapsulation
H Uludag et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF
AC Bachoud-Lévi et al.
HUMAN GENE THERAPY (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Encapsulation matrices for neurotrophic factor-secreting myoblast cells
RH Li et al.
TISSUE ENGINEERING (2000)
Share Paper
